The DOI matches its Crossref record; 450 of the 450 references it cites were found in a registry or an index.
The Thioredoxin System as a Therapeutic Target in Human Health and Disease
Abstract
The thioredoxin (Trx) system comprises Trx, truncated Trx (Trx-80), Trx reductase, and NADPH, besides a natural Trx inhibitor, the thioredoxin-interacting protein (TXNIP). This system is essential for maintaining the balance of the cellular redox status, and it is involved in the regulation of redox signaling. It is also pivotal for growth promotion, neuroprotection, inflammatory modulation, antiapoptosis, immune function, and atherosclerosis. As an ubiquitous and multifunctional protein, Trx is expressed in all forms of life, executing its function through its antioxidative, protein-reducing, and signal-transducing activities. In this review, the biological properties of the Trx system are highlighted, and its implications in several human diseases are discussed, including cardiovascular diseases, heart failure, stroke, inflammation, metabolic syndrome, neurodegenerative diseases, arthritis, and cancer. The last chapter addresses the emerging therapeutic approaches targeting the Trx system in human diseases. Antioxid. Redox Signal. 19, 1266–1303. I. Oxidative Stress—the Underlying Cause of Many Diseases II. The Trx System A. The Trx-1 gene B. Structure of Trx-1 C. Truncated Trx D. The Trx reductases E. Trx-interacting protein F. Regulation and post-translational modifications of Trx G. Regulation of cell signaling by Trx1 1. Extracellular Trx1 2. Cytoplasmic Trx1 a. Mitogen-activated protein kinases b. Calcium signaling 3. Nuclear Trx1 III. General Functions of Trx A. Role of Trx inapoptosis B. Trx regulates glucocorticoid and ERs IV. The Trx System and Aging V. The Trx System in CVD VI. Physical Exercise and the Trx System VII. The Trx System in the Metabolic Syndrome VIII. The Trx System in Immunity IX. The Trx System and Cancer X. The Trx System in Neurodegenerative Diseases A. Alzheimer's disease B. Parkinson's disease XI. Trx System in RA XII. Trx in Inflammatory Airway Diseases XIII. The Trx System as a Therapeutic Target A. Thioredoxin B. Trx reductase C. Trx-interacting protein XIV. Conclusions
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 401–450 of 450
Thioredoxin in human and experimental sepsis*
Hofer, S., Rosenhagen, C., Nakamura, H., Yodoi, J., Bopp, C., Zimmermann, J. B., Goebel, M., Schemmer, P., Hoffmann, K., Schulze‐Osthoff, K., et al. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819fff67 · Cited by 39
Silberstein, D. S., Ali, M., Baker, S. L., & David, J. R. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.3.979 · Cited by 38
Hoshida, S., Nishida, M., Yamashita, N., Igarashi, J., Hori, M., Kamada, T., Kuzuya, T., & Tada, M. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00538-2 · Cited by 37
Thioredoxin reductase inactivation as a pivotal mechanism of ifosfamide in cancer therapy
Wang, X., Zhang, J., & Xu, T. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.10.012 · Cited by 37
Lowes, D. A., & Galley, H. F. (2011) · Biochemical Journal · doi:10.1042/bj20102135 · Cited by 37
Naoi, M., Maruyama, W., Inaba-Hasegawa, K., & Akao, Y. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-386467-3.00005-4 · Cited by 35
Kamimoto, Y., Sugiyama, T., Kihira, T., Zhang, L., 村林, 奈., Umekawa, T., Nagao, K., Ma, N., Toyoda, N., Yodoi, J., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1784-y · Cited by 35
Kondo, N., Ishii, Y., Kwon, Y.-W., Tanito, M., Sakakura-Nishiyama, J., Mochizuki, M., Maeda, M., Suzuki, S., Kojima, M., Kim, Y., et al. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1665 · Cited by 34
Umekawa, T., Sugiyama, T., Kihira, T., 村林, 奈., Zhang, L., Nagao, K., Kamimoto, Y., Ma, N., Yodoi, J., & Sagawa, N. (2008) · Endocrinology · doi:10.1210/en.2007-1682 · Cited by 34
Oxidative Stress in Cardiovascular Inflammation: Its Involvement in Autoimmune Responses
Profumo, E., Buttari, B., & Riganò, R. (2011) · International Journal of Inflammation · doi:10.4061/2011/295705 · Cited by 33
Impairment of thioredoxin reductase activity by oxidative stress in human rheumatoid synoviocytes
Lemaréchal, H., Anract, P., Beaudeux, J., Bonnefont‐Rousselot, D., Ekindjian, O. G., & Borderie, D. (2007) · Free Radical Research · doi:10.1080/10715760701294468 · Cited by 32
Thioredoxin liquefies and decreases the viscoelasticity of cystic fibrosis sputum
Rancourt, R. C., Tai, S., King, M., Heltshe, S. L., Penvari, C., Accurso, F. J., & White, C. W. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00352.2003 · Cited by 32
Thioredoxin Overexpression in Transgenic Mice
Nakamura, H., Mitsui, A., & Yodoi, J. (2002) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(02)47043-7 · Cited by 31
Thioredoxin in Allergic Inflammation
Ito, W., Kobayashi, N., Takeda, M., Ueki, S., Kayaba, H., Nakamura, H., Yodoi, J., & Chihara, J. (2011) · International Archives of Allergy and Immunology · doi:10.1159/000327501 · Cited by 31
Thioredoxin-Interacting Protein Is Killing My β-cells!
Corbett, J. A. (2008) · Diabetes · doi:10.2337/db08-0055 · Cited by 31
King, B. C., Nowakowska, J., Karsten, C. M., Köhl, J., Renström, E., & Blom, A. M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101295 · Cited by 31
Chen, B., Guan, D., Cui, Z. J., Wang, X., & Shen, X. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00223.2009 · Cited by 30
Isowa, N., Yoshimura, T., Kosaka, S., Liu, M., Hitomï, S., Yodoi, J., & Wada, H. (2000) · Journal of Cellular Physiology · Cited by 30
Han, Y., Shin, D., Lee, Y., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.11.114 · Cited by 30
Oblong, J. E., Chantler, E. L., Gallegos, A. C., Kirkpatrick, D. L., Chen, T., Marshall, N., & Powis, G. (1994) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685570 · Cited by 29
Application of recombinant thioredoxin1 for treatment of heart disease
Matsushima, S., Zablocki, D., & Sadoshima, J. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.09.020 · Cited by 29
Role of Inflammasomes in Salmonella Infection
Franchi, L. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00008 · Cited by 29
Selenoprotein expression in endothelial cells from different human vasculature and species
Miller, S., Walker, S. W., Arthur, J. R., Lewin, M., Pickard, K., Nicol, F., Howie, A. F., & Beckett, G. J. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00143-6 · Cited by 29
Modulation of Inflammasome Activity for the Treatment of Auto-inflammatory Disorders
Naik, E., & Dixit, V. M. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9383-8 · Cited by 28
Kim, S.-H., Choi, G., Ye, Y.-M., Jou, I., Park, H.-S., & Park, S. M. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04118.x · Cited by 27
Ono, R., Masaki, T., Dien, S., Yu, X., Fukunaga, A., Yodoi, J., & Nishigori, C. (2012) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2012.01566.x · Cited by 26
Skogastierna, C., Johansson, M., Parini, P., Eriksson, M., Eriksson, L. C., Ekström, L., & Björkhem‐Bergman, L. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.12.091 · Cited by 26
Inomata, Y., Tanihara, H., Tanito, M., Okuyama, H., Hoshino, Y., Kinumi, T., Kawaji, T., Kondo, N., Yodoi, J., & Nakamura, H. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1659 · Cited by 26
Billiet, L., Furman, C., Cuaz‐Pérolin, C., Paumelle, R., Raymondjean, M., Simmet, T., & Rouis, M. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.09.061 · Cited by 25
Self-citationLiu, G., Qu, J. T., & Shen, X. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-10-0979 · Cited by 24
On oxidative status and cardiovascular risk in women: Keeping pink at heart
Vassalle, C. (2009) · World Journal of Cardiology · doi:10.4330/wjc.v1.i1.26 · Cited by 23
Functional and Mechanistic Integration of Infection and the Metabolic Syndrome
Sommer, P., & Sweeney, G. (2010) · Korean Diabetes Journal · doi:10.4093/kdj.2010.34.2.71 · Cited by 23
Kapakos, G., Youreva, V., & Srivastava, A. K. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y2012-059 · Cited by 23
Increased thioredoxin-1 inhibits SSAT expression in MCF-7 human breast cancer cells
Husbeck, B., Stringer, D. E., Gerner, E. W., & Powis, G. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00993-8 · Cited by 22
Strategies that modulate inflammasomes—insights from host–pathogen interactions
Johnston, J. B., Rahman, M. M., & McFadden, G. (2007) · Seminars in Immunopathology · doi:10.1007/s00281-007-0080-5 · Cited by 22
Lemaréchal, H., Anract, P., Beaudeux, J., Bonnefont‐Rousselot, D., Ekindjian, O. G., & Borderie, D. (2007) · Clinical Science · doi:10.1042/cs20070067 · Cited by 21
Theobald, A. J., Caballero, I., Coma, I., Colmenarejo, G., Cid, C., Gamo, F., Hibbs, M. J., Bass, A. L., & Thomas, D. A. (2012) · Biochemistry · doi:10.1021/bi3005076 · Cited by 21
Loss of thioredoxin function in retinas of mice overexpressing amyloid β
Lamoke, F., Ripandelli, G., Webster, S. J., Montemari, A. L., Maraschi, A., Martin, P. M., Marcus, D. M., Liou, G. I., & Bartoli, M. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.04.010 · Cited by 20
Structure of human thioredoxin exhibits a large conformational change
Hall, G., & Emsley, J. (2010) · Protein Science · doi:10.1002/pro.466 · Cited by 20
Studies on Cardiovascular Disorders
Sauer, H., Shah, A. M., & Laurindo, F. R. M. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-600-9 · Cited by 19
Changes in thioredoxin concentrations: an observation in an ultra-marathon race
Marumoto, M., Suzuki, S., Hosono, A., Arakawa, K., Shibata, K., Fuku, M., Goto, C., Tokudome, Y., Hoshino, H., Imaeda, N., et al. (2009) · Environmental Health and Preventive Medicine · doi:10.1007/s12199-009-0119-4 · Cited by 17
Osborne, S. A., Hawkes, H.-J. K., Baldwin, B. L., Alexander, K. A., Svingen, T., Clarke, F. M., & Tonissen, K. F. (2006) · Biochemical Journal · doi:10.1042/bj20060076 · Cited by 17
Chuang, C., Chang, C., & Huang, Y. (2008) · Inhalation Toxicology · doi:10.1080/08958370802368730 · Cited by 17
Ji, J., Pan, E., Li, J., Chen, J., Cao, J., Sun, D., Lu, X., Chen, S., Gu, D., Duan, X., et al. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-497 · Cited by 15
Fishelson, L., & Baranes, A. (1998) · The Anatomical Record · doi:10.1002/(sici)1097-0185(199812)252:4<532::aid-ar4>3.0.co;2-g · Cited by 13
Increased skin carcinogenesis in a keratinocyte directed thioredoxin-1 transgenic mouse
Mustacich, D. J., Wagner, A., Williams, R., Bair, W., Barbercheck, L., Stratton, S. P., Bhattacharyya, A. K., & Powis, G. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh195 · Cited by 12
Targeting the Human Thioredoxin System by Diverse Strategies to Treat Cancer and Other Pathologies
Tonissen, K. F. (2007) · Recent Patents on DNA & Gene Sequences · doi:10.2174/187221507782360227 · Cited by 10
Aguado‐Llera, D., Martínez‐Gómez, A. I., Prìeto, J., Marenchino, M., Traverso, J. A., Gómez, J., Chueca, A., & Neira, J. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017068 · Cited by 9
Protective effect of thioredoxin perfusion but not inhalation in warm ischemic-reperfused rat lungs
Zhang, J., Chen, F., Nakamura, T., Fujinaga, T., Aoyama, A., Hamakawa, H., Sakai, H., Hoshino, Y., Yodoi, J., Wada, H., et al. (2009) · Redox Report · doi:10.1179/135100009x392511 · Cited by 8
Inflammation in Atherosclerosis: New Opportunities for Drug Discovery
Meng, C. Q. (2005) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557053402792 · Cited by 6
Cited by
Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer
Mármol, I., Sánchez-de-Diego, C., Pradilla Dieste, A., Cerrada, E., & Rodriguez Yoldi, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010197 · Cited by 1,525
Chalcone: A Privileged Structure in Medicinal Chemistry
Zhuang, C., Zhang, W., Sheng, C., Zhang, W., Xing, C., & Miao, Z. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00020 · Cited by 1,463
Hydrogen peroxide – production, fate and role in redox signaling of tumor cells
Lennicke, C., Rahn, J., Lichtenfels, R., Wessjohann, L. A., & Seliger, B. (2015) · Cell Communication and Signaling · doi:10.1186/s12964-015-0118-6 · Cited by 571
Paradoxical Roles of Antioxidant Enzymes: Basic Mechanisms and Health Implications
Lei, X. G., Zhu, J.-H., Cheng, W.-H., Bao, Y., Ho, Y.-S., Reddi, A. R., Holmgren, A., & Arnér, E. S. J. (2016) · Physiological Reviews · doi:10.1152/physrev.00010.2014 · Cited by 429
RONS and Oxidative Stress: An Overview of Basic Concepts
Aranda-Rivera, A. K., Cruz-Gregorio, A., Arancibia-Hernández, Y. L., Hernández-Cruz, E. Y., & Pedraza-Chaverri, J. (2022) · Oxygen · doi:10.3390/oxygen2040030 · Cited by 384
Metadata
- Authors
- Mahmood, D. F. D., Abderrazak, A., El Hadri, K., Simmet, T., & Rouis, M.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2013-10-10
- Volume
- 19
- Issue
- 11
- Pages
- 1266-1303
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W2003738619
- Cited by
- 305
- References
- 450
- FWCI
- 8.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.